Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial

Abstract

MERTK is an essential component of the signaling network that controls phagocytosis in retinal pigment epithelium (RPE), the loss of which results in photoreceptor degeneration. Previous proof-of-concept studies have demonstrated the efficacy of gene therapy using human MERTK (hMERTK) packaged into adeno-associated virus (AAV2) in treating RCS rats and mice with MERTK deficiency. The purpose of this study was to assess the safety of gene transfer via subretinal administration of rAAV2-VMD2-hMERTK in subjects with MERTK-associated retinitis pigmentosa (RP). After a preclinical phase confirming the safety of the study vector in monkeys, six patients (aged 14 to 54, mean 33.3 years) with MERTK-related RP and baseline visual acuity (VA) ranging from 20/50 to <20/6400 were entered in a phase I open-label, dose-escalation trial. One eye of each patient (the worse-seeing eye in five subjects) received a submacular injection of the viral vector, first at a dose of 150 µl (5.96 × 10(10)vg; 2 patients) and then 450 µl (17.88 × 10(10)vg; 4 patients). Patients were followed daily for 10 days at 30, 60, 90, 180, 270, 365, 540, and 730 days post-injection. Collected data included (1) full ophthalmologic examination including best-corrected VA, intraocular pressure, color fundus photographs, macular spectral domain optical coherence tomography and full-field stimulus threshold test (FST) in both the study and fellow eyes; (2) systemic safety data including CBC, liver and kidney function tes…

Overview

Integrity signals

Registry

Crossref · 10.1007/s00439-016-1637-y

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 43 references

Cited by

See all 243

Metadata

Authors
Ghazi, N. G., Abboud, E. B., Nowilaty, S. R., Alkuraya, H., Alhommadi, A., Cai, H., Hou, R., Deng, W.-T., Boye, S. L., Almaghamsi, A., Al Saikhan, F., Al-Dhibi, H., Birch, D., Chung, C., Colak, D., LaVail, M. M., Vollrath, D., Erger, K., Wang, W., Conlon, T., Zhang, K., Hauswirth, W., & Alkuraya, F. S.
Affiliations
  • King Khaled Eye Specialist Hospital (SA)
  • Imam Mohammad ibn Saud Islamic University (SA)
  • University of California San Diego (US)
  • University of Florida (US)
  • Retina Foundation of the Southwest (US)
  • University of California, San Francisco (US)
  • Stanford Medicine (US)
  • Alfaisal University (SA)
Corresponding author
Alkuraya, Fowzan S.
Venue
Human Genetics
Published
2016-01-29
Volume
135
Issue
3
Pages
327-343
ISSN
  • 0018-7348 (ISSN-L)
  • 0340-6717
  • 1432-1203
OpenAlex
W2255190151
Cited by
243
References
43
Citations by year
2026: 11 · 2025: 18 · 2024: 22 · 2023: 10 · 2022: 26 · 2021: 30 · 2020: 22 · 2019: 26 · 2018: 31 · 2017: 32 · 2016: 13
FWCI
17.66
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Human Genetics (publishedVersion)
  • PubMed (publishedVersion)
Funders
King Salman Center for Disaiblity Research
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
Keywords
retinitis pigmentosa, gene therapy, adeno-associated virus vectors, AAV2, subretinal injection, retinal pigment epithelium, phagocytosis, photoreceptor degeneration, vector safety, dose escalation, visual acuity, retinal function, adverse events
MeSH terms
c-Mer Tyrosine Kinase, Dependovirus, Adolescent, Adult, Animals, Disease Models, Animal, Female, Follow-Up Studies, Genetic Vectors, Humans, Macaca, Male, Middle Aged, Mutation, Postoperative Complications, Proto-Oncogene Proteins, Retinitis Pigmentosa, Visual Acuity, Genetic Therapy, Treatment Outcome, Receptor Protein-Tyrosine Kinases, Endpoint Determination, Tomography, Optical Coherence, Young Adult, Subretinal Fluid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial. https://app.cochat.ai/papers/10.1007/s00439-016-1637-y
The paper
Ghazi, N. G., Abboud, E. B., Nowilaty, S. R., Alkuraya, H., Alhommadi, A., Cai, H., Hou, R., Deng, W.-T., Boye, S. L., Almaghamsi, A., Al Saikhan, F., Al-Dhibi, H., Birch, D., Chung, C., Colak, D., LaVail, M. M., Vollrath, D., Erger, K., Wang, W., . . . Alkuraya, F. S. (2016). Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial. Human Genetics. https://doi.org/10.1007/s00439-016-1637-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.